Personalized Psychiatry Industry Anticipated to Expand at 14.4% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Personalized Psychiatry Market From 2025 To 2034?

The personalized psychiatry market size has demonstrated rapid expansion in recent years. It is anticipated to grow from $5.69 billion in 2024 to $6.51 billion in 2025, advancing at a compound annual growth rate (CAGR) of 14.5%. The historical development of this market can be attributed to heightened awareness concerning mental health, a growing prevalence of psychiatric disorders, an increasing demand for personalized healthcare solutions, rising healthcare expenditures, and improved healthcare access along with affordability.

The personalized psychiatry market is projected to experience substantial growth in the upcoming years. Its valuation is forecast to reach $11.16 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.4%. This anticipated growth during the forecast period can be attributed to several factors, including the increasing application of digital therapeutics, a greater need for remote patient monitoring, a surge in demand for mental health solutions post-COVID-19, enhanced investments in mental health from both government and private sectors, and the desire for more readily available mental healthcare options. Key trends expected during the forecast period encompass a more advanced utilization of artificial intelligence for diagnosing mental health conditions, the rising adoption of telepsychiatry and virtual consultations, the incorporation of blockchain technology for securing mental health data, an increase in the deployment of virtual reality (VR) for therapeutic purposes, and the proliferation of wearable devices for tracking mental health.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

Which Drivers Are Shaping The Personalized Psychiatry Industry’s Market Share?

The escalating prevalence of mental health challenges is projected to drive the expansion of the personalized psychiatry market in the future. These issues encompass a broad spectrum of conditions impacting an individual’s emotional, psychological, and social welfare. The rise in mental health concerns stems from escalating stress and lifestyle factors, primarily attributed to demanding work environments, an imbalance between work and personal life, and insufficient coping mechanisms. Personalized psychiatry addresses mental health conditions by providing customized treatment regimens that consider a patient’s unique biological, psychological, and lifestyle attributes. This approach improves the efficacy of care, minimizing experimental treatments and resulting in quicker recovery periods and better patient outcomes. As an illustration, data from the National Institute of Mental Health, a US-based federal government research agency, revealed that in 2022, approximately 59.3 million adults aged 18 and older in the United States were estimated to be experiencing any mental illness (AMI), representing 23.1% of the overall adult populace. Consequently, the growing incidence of mental health problems is propelling the expansion of the personalized psychiatry market.

What Are The Primary Types Of Segments Analyzed In The Personalized Psychiatry Market?

The personalized psychiatrymarket covered in this report is segmented –

1) By Type: Products; Services; Software

2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics

3) By Application: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics; Hospitals; Research Institutes; Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits; Wearable Devices; Brain Imaging Devices

2) By Services: Telepsychiatry; Personalized Treatment Planning; Behavioral Assessment

3) By Software: Clinical Decision Support Tools; Mental Health Apps; Virtual Therapy Platforms

What Key Innovation Trends Are Fueling Advancements In The Personalized Psychiatry Market?

Major companies in the personalized psychiatry market are concentrating on developing technologically advanced services, such as personalized telepsychiatry services, to improve access to individualized mental health care via a flexible, patient-centered service model. Personalized telepsychiatry offers a remote mental healthcare approach that delivers tailored psychiatric evaluation and treatment, informed by an individual’s unique genetic, environmental, and lifestyle factors, through digital communication platforms. For instance, in April 2025, Alice’s Psychiatry & Wellness, a US-based psychiatry and wellness service company, inaugurated a clinic to provide compassionate, personalized psychiatric care for adults across multiple states, utilizing both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to customize psychiatric medications based on each patient’s genetic profile, thereby enhancing treatment effectiveness and reducing adverse effects. The clinic further leverages virtual platforms and continuous care from a dedicated provider to deliver accessible, consistent, and inclusive mental health support, aligning fully with the principles of personalized psychiatry.

Who Are The Major Companies Operating In The Personalized Psychiatry Market?

Major companies operating in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, BrightQuest Treatment Centers, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, GreyBird Ventures, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

Which Region Is Projected To Lead The Personalized Psychiatry Market During The Forecast Period?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Personalized Psychiatry Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Browse Through More Reports Similar to the Global Personalized Psychiatry Market 2025, By The Business Research Company

Telepsychiatry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Ai In Mental Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-mental-health-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795